Comparison of the Clinical Outcomes Between Early and Delayed Transplantation After SARS-CoV-2Infection
Journal of Korean Medical Science
; : e137-2024.
Article
de En
| WPRIM
| ID: wpr-1043494
Bibliothèque responsable:
WPRO
ABSTRACT
Our study analyzed 95 solid organ transplant (SOT) and 78 hematopoietic stem cell transplant (HSCT) recipients with prior coronavirus disease 2019 (COVID-19). Patients who underwent transplantation within 30 days of COVID-19 infection comprised the early group, and those who underwent transplantation post-30 days of COVID-19 infection comprised the delayed group. In the early transplantation group, no patient, whether undergoing SOT and HSCT, experienced COVID-19-associated complications. In the delayed transplantation group, one patient each from SOT and HSCT experienced COVID-19-associated complications. Additionally, among early SOT and HSCT recipients, two and six patients underwent transplantation within seven days of COVID-19 diagnosis, respectively. However, no significant differences were observed in the clinical outcomes of these patients compared to those in other patients. Early transplantation following severe acute respiratory syndrome coronavirus 2 infection can be performed without increased risk of COVID-19-associated complications. Therefore, transplantation needs not be delayed by COVID-19 infection.
Texte intégral:
1
Indice:
WPRIM
langue:
En
Texte intégral:
Journal of Korean Medical Science
Année:
2024
Type:
Article